[Form 4] Ambarella, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Ambarella, Inc. director Hsiao-Wuen Hon received an annual restricted stock unit (RSU) award of 2,498 ordinary shares, effective September 2, 2025. The filing shows the grant was approved by the Board and reported on Form 4, with 30,776 shares reported as beneficially owned by Mr. Hon after the award. The RSUs vest in four quarterly installments beginning September 15, 2025, with 1/4th of the shares vesting each three months and full vesting on September 15, 2026, subject to continued service. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Annual RSU grant disclosed: 2,498 RSUs granted to each independent director effective 09/02/2025
- Clear vesting schedule: RSUs vest 1/4th every three months from 09/15/2025 to full vesting on 09/15/2026
Negative
- None.
Insights
TL;DR: A routine director equity grant of 2,498 RSUs with one-year quarterly vesting, increasing reported beneficial ownership to 30,776 shares.
This Form 4 discloses a standard annual compensation equity award for an independent director rather than a market-facing transaction. The grant size is specified and the vesting timetable is explicit, which clarifies future dilution timing for shareholders. The report does not include any cash transactions or option exercises and contains no indications of unusual insider trading.
TL;DR: Board-approved RSU grant aligns with typical director compensation practices and vests over one year conditioned on continued service.
The disclosure indicates board-level approval of an annual RSU award for independent directors and provides a clear vesting schedule tied to service through September 15, 2026. The filing is procedurally complete, signed by an authorized attorney-in-fact, and reports the change in beneficial ownership consistent with Section 16 requirements.